Loading…

Advancing Clinical Trials in Nursing Homes: A Proposed Roadmap to Success

An effective clinical research effort in nursing homes to address prevention and treatment of COVID‐19 faced overwhelming challenges. Under the Health Care Systems Research Network‐Older Americans Independence Centers AGING Initiative, a multidisciplinary Stakeholder Advisory Panel was convened to d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Geriatrics Society (JAGS) 2022-03, Vol.70 (3), p.701-708
Main Authors: Gurwitz, Jerry H., Quinn, Charlene C., Abi‐Elias, Ivan H., Adams, Alyce S., Bartel, Rosie, Bonner, Alice, Boxer, Rebecca, Delude, Christopher, Gifford, David, Hanson, Bruce, Ito, Kouta, Jain, Paavani, Magaziner, Jay S., Mazor, Kathleen M., Mitchell, Susan L., Mody, Lona, Nace, David, Ouslander, Joseph, Reifsnyder, Jo Anne, Resnick, Barbara, Zimmerman, Sheryl
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An effective clinical research effort in nursing homes to address prevention and treatment of COVID‐19 faced overwhelming challenges. Under the Health Care Systems Research Network‐Older Americans Independence Centers AGING Initiative, a multidisciplinary Stakeholder Advisory Panel was convened to develop recommendations to improve the capability of the clinical research enterprise in US nursing homes. The Panel considered the nursing home as a setting for clinical trials, reviewed the current state of clinical trials in nursing homes, and ultimately developed recommendations for the establishment of a nursing home clinical trials research network that would be centrally supported and administered. This report summarizes the Panel's recommendations, which were developed in alignment with the following core principles: build on available research infrastructure where appropriate; leverage existing productive partnerships of researchers with groups of nursing homes and nursing home corporations; encompass both efficacy and effectiveness clinical trials; be responsive to a broad range of stakeholders including nursing home residents and their care partners; be relevant to an expansive range of clinical and health care delivery research questions; be able to pivot as necessary to changing research priorities and circumstances; create a pathway for industry‐sponsored research as appropriate; invest in strategies to increase diversity in study populations and the research workforce; and foster the development of the next generation of nursing home researchers. See related editorial by Zimmerman et al. and Special Articles by Levy et al. and Resnick et al. in this issue.
ISSN:0002-8614
1532-5415
1532-5415
DOI:10.1111/jgs.17696